Condition: Chronic Granulomatous Disease X-linked (X-CGD) · Sponsor: IRCCS San Raffaele
This is a phase II exploratory study conducted to evaluate the safety and efficacy of the combination of Ibuprofen, G-CSF and Plerixafor as stem cell mobilization regimen in patients affected by X-CGD.
This description comes directly from the study's public registry record.
Fabio Ciceri, MD, PhD · 39 02.2643.3903 · ciceri.fabio@hsr.it
Alessandro Aiuti, MD, PhD · +390226434875 · aiuti.alessandro@hsr.it
Always discuss trial participation with your own doctor first.
| Ospedale Pediatrico Bambino Gesù | Rome, Lazio, Italy | Recruiting |
| Ospedale San Raffaele | Milan, Lombardy, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03055247